More than two months after Blueprint Medicines Corp. gained a broadened label for Ayvakit (avapritinib), the company is “really pleased to see the diversity of revenue this early in the launch across ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback